Omalizumab

Therapeutic Group

Drugs For Obstructive Airway Diseases, Systemic

Indication Dosage

Prophylaxis Of Severe Persistent Allergic Asthma: 

By Sc Inj: 

  • Adult: Dose According To Immunoglobulin E concentration and body weight (consult Productliterature) 

Add-on Therapy For Chronic Spontaneous Urticaria In Patients With Inadequate Response To H1 Antihistamine Treatment: 

By Sc Inj: 

  • Adult: 300 Mg Every 4 Weeks

Content

  • Inj: Per ml: Omalizumab 125mg, Powder N Vial And Solvent In Amp.

Pregnancy

Avoid Unless Essential

Stability

  • Immunosuppressants
  • Monoclonal Antibody

Contra Indications

  • Acute Asthma, Acute Bronchospasm, Status Asthmatic.

Precautions

  • Acute Asthma, Acute Bronchospasm, Status Asthmatic.

Lactation

  • Caution Advised or Avoid Unless Essential

Side Effects

  • Lnj Site Reactions
  • Headache
  • Anaphylactic Reactions.

Available Brands